What 2025 means for the life sciences sector in the New Year. If I had to describe 2025 in one phrase, it would be this: a year of two halves, held together by uncertainty.
Since TrumpRx was announced in 2025, 16 Big Pharma companies have agreed to sell their drugs via the platform, including ...
Within the context of “The Great Repricing,” this distinction matters. The pressure on the commercial channel is not coming ...
In reality, program design covers everything from offer amount and caps to eligibility rules and channel mix, yet many ...
In today’s Pharma Pulse, the FTC secures a multi-billion-dollar settlement against the "rebate trap," while Congress provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results